Home > Insider Trading > Filing (0001209191-20-033993)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1643921	N. Sangeeta Bhatia	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-06-01	1,398	$0.00	6,647	No	4	A	Direct
Common Stock	Disposition	2020-06-02	50	$279.52	6,597	No	4	S	Direct
Common Stock	Disposition	2020-06-02	200	$281.20	6,397	No	4	S	Direct
Common Stock	Disposition	2020-06-02	313	$282.86	6,084	No	4	S	Direct
Common Stock	Disposition	2020-06-02	289	$283.84	5,795	No	4	S	Direct
Common Stock	Disposition	2020-06-02	50	$284.62	5,745	No	4	S	Direct
Common Stock	Disposition	2020-06-02	50	$285.73	5,695	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.
Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $281.20 (range $281.01 to $281.66).
Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $282.86 (range $282.36 to $283.31).
Open market sales reported on this line occurred at a weighted average price of $283.84 (range $283.47 to $284.23).